Interview part two: Chang Yi Wang, Chairperson & CEO, UBI Asia, and…
In the second part of this two-part interview, the Chairperson of UBI and UBI Asia offers her thoughts on the challenges and opportunities of the Chinese market, and explains her…
UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
The company’s product pipeline is filled with a new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, and Allergy, along with a portfolio of animal health diseases. These products are based on UBI’s proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies. The company’s platform technologies are also being used to develop a line of biosimilar versions of widely used protein and antibody drugs whose patents are about to expire.
UBI’s proprietary designer peptide technology has been used to produce a line of blood screening diagnostics and the first successfully commercialized synthetic peptide vaccine. Additional revenue streams are generated from pharmaceutical contract manufacturing by the company’s subsidiary UBI-Asia and various sponsorships in product development.
Rm. E, 52F., No.7-5,
Sec. 5, Xinyi Rd.,
Xinyi Dist.,
Taipei City
11049,
Taiwan (R.O.C.)
Tel:886-2-8101-0101
Fax:886-2-8101-0100
In the second part of this two-part interview, the Chairperson of UBI and UBI Asia offers her thoughts on the challenges and opportunities of the Chinese market, and explains her…
In the first of this two-part interview, the chairperson of UBI and UBI Asia explains the work that her company has done to improve the landscape for Taiwanese pharma and…
Dr Huey-Jen Jenny Su, president of National Cheng Kung University, elaborates on her ambitions to reclaim the institution’s unique historical positioning as Taiwan’s most impactful university. She goes on to…
Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO…
Ying-Yao Cheng, president of National Sun Yat-sen University, highlights the institution’s specialized expertise in marine sciences and goes on to elaborate on the important role of NSYSU in developing talent,…
Adimmune Corporation is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP manufacturer of human vaccines in…
Nick Lee, general manager of Ipsen Taiwan, Hong Kong, and Macau, shares his journey of building up the affiliate after having separated from their local partner two years ago. Lee…
Jenny Chao and Aries Chang of BiotechTS, introduce the company as a leading one-stop-service provider for laboratory testing and explain its current transition from the food and safety space to…
Sheron Lin, president of Daiichi Sankyo Taiwan, elaborates on the affiliate’s tactical positioning in the region and a leading market for clinical trials and new product launches. Lin goes on…
Polly Lin, CEO of Guzip Biomarkers, discusses Guzip’s work in epigenetics and the role of DNA methylation in treating endometrial cancer. She highlights the benefits of MPap for women’s health…
Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s global office in Denmark. Profit goes on to…
Dr Fuh-Sheng Shieu, president of National Chung Hsing University, elaborates on his ambitions to further NCHU’s positioning as one of Taiwan’s most impactful research universities. He goes on to highlight…
EPED is a professional medical equipment company and a leader in navigation system technologies based in Taiwan. Here, Founder & President Douglas Huang discusses EPED’s medical, dental and educational training…
Medimaging Integrated Solution Inc (MiiS) originated from the incubation center at the National Chiao Tung University (NCTU), Taiwan. MiiS started its business primarily based on the foundation of innovation, and…
See our Cookie Privacy Policy Here